- Home
- CELU vs COCH Comparison
CELU vs COCH Comparison
Compare CELU & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- COCH
- Stock Information
- Founded
- CELU 2016
- COCH 1995
- Country
- CELU United States
- COCH United States
- Employees
- CELU N/A
- COCH N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- CELU Health Care
- COCH Finance
- Exchange
- CELU Nasdaq
- COCH Nasdaq
- Market Cap
- CELU 37.7M
- COCH 31.6M
- IPO Year
- CELU N/A
- COCH N/A
- Fundamental
- Price
- CELU $2.29
- COCH $1.63
- Analyst Decision
- CELU
- COCH Strong Buy
- Analyst Count
- CELU 0
- COCH 2
- Target Price
- CELU N/A
- COCH $9.13
- AVG Volume (30 Days)
- CELU 91.4K
- COCH 23.4K
- Earning Date
- CELU 05-08-2025
- COCH 05-01-2025
- Dividend Yield
- CELU N/A
- COCH N/A
- EPS Growth
- CELU N/A
- COCH N/A
- EPS
- CELU N/A
- COCH N/A
- Revenue
- CELU $54,220,000.00
- COCH $212,000.00
- Revenue This Year
- CELU $23.29
- COCH $8.04
- Revenue Next Year
- CELU N/A
- COCH $29.37
- P/E Ratio
- CELU N/A
- COCH N/A
- Revenue Growth
- CELU 138.11
- COCH N/A
- 52 Week Low
- CELU $1.00
- COCH $1.21
- 52 Week High
- CELU $5.22
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- CELU 62.18
- COCH 56.35
- Support Level
- CELU $1.90
- COCH $1.60
- Resistance Level
- CELU $2.11
- COCH $1.79
- Average True Range (ATR)
- CELU 0.28
- COCH 0.14
- MACD
- CELU 0.07
- COCH 0.00
- Stochastic Oscillator
- CELU 75.73
- COCH 37.78
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.